U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C36H61O11.Na
Molecular Weight 692.8527
Optical Activity UNSPECIFIED
Defined Stereocenters 17 / 17
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MONENSIN SODIUM

SMILES

[Na+].CC[C@]1(CC[C@@H](O1)[C@@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@H](C)[C@H](OC)[C@@H](C)C([O-])=O)O2)[C@H]4O[C@@H](C[C@H]4C)[C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C

InChI

InChIKey=XOIQMTLWECTKJL-PDHYURILSA-M
InChI=1S/C36H62O11.Na/c1-10-34(31-20(3)16-26(43-31)28-19(2)15-21(4)36(41,18-37)46-28)12-11-27(44-34)33(8)13-14-35(47-33)17-25(38)22(5)30(45-35)23(6)29(42-9)24(7)32(39)40;/h19-31,37-38,41H,10-18H2,1-9H3,(H,39,40);/q;+1/p-1/t19-,20+,21+,22+,23+,24+,25-,26-,27+,28-,29-,30-,31-,33+,34-,35+,36-;/m0./s1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C36H61O11
Molecular Weight 669.8629
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 17 / 17
E/Z Centers 0
Optical Activity UNSPECIFIED

Monensin is an antibiotic produced as a byproduct of fermentation by Streptomyces cinnamonensis and belongs to a family of drugs known as polyether antibiotics or ionophores. The drug was approved by FDA for the prevention of coccidiosis in turkeys, chickens, quail, cattle, goats, calves (Coban, Rumensin). The exact mechanism of monesin action is unknown, however there are several hypotesis, which includes the inhibition of K+ transport, the inhibition of the transport of carbohydrates across the host cell membrane, the interruption host cell invasion by sporozoites, etc.

Originator

Curator's Comment: # Eli Lilly and the Department of Biochemistry of Indiana University School of Medicine

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
COBAN

Approved Use

For the prevention of coccidiosis.

Launch Date

1987
PubMed

PubMed

TitleDatePubMed
Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.
2002-02-22
Constitutive internalization of constitutively active agiotensin II AT(1A) receptor mutants is blocked by inverse agonists.
2002-02-22
Organization of cyclic AMP-dependent connexin 43 in Swiss 3T3 cells attached to a cellulose substratum.
2002-01
Detection of two distinct transporter systems for 2-deoxyglucose uptake by the opportunistic pathogen Pneumocystis carinii.
2001-12-01
Engineering of complex polyketide biosynthesis--insights from sequencing of the monensin biosynthetic gene cluster.
2001-12
Acidic vesicles of Schistosoma mansoni.
2001-12
Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular.
2001-12
Regulation of Ca(2+) signals in a parotid cell line Par-C5.
2001-12
Efficient and sensitive screening and confirmation of residues of selected polyether ionophore antibiotics in liver and eggs by liquid chromatography-electrospray tandem mass spectrometry.
2001-11
Rhabdomyolysis, acute renal failure, and death after monensin ingestion.
2001-11
NAD degradation and regulation of CD38 expression by human monocytes/macrophages.
2001-11
The importance of Na+/H+ exchanger for the generation of procoagulant activity by porcine blood platelets.
2001-11
Conjugation of anti-My9 antibody to stealth monensin liposomes and the effect of conjugated liposomes on the cytotoxicity of immunotoxin.
2001-10-19
Prion protein protects human neurons against Bax-mediated apoptosis.
2001-10-19
Long-lasting aberrant tubulovesicular membrane inclusions accumulate in developing motoneurons after a sublethal excitotoxic insult: a possible model for neuronal pathology in neurodegenerative disease.
2001-10-15
Hydrogen peroxide activates Na(+)-dependent Ca(2+) influx in coronary endothelial cells.
2001-10-12
Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts.
2001-10
Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
2001-10
Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase.
2001-10
Gap junction assembly: PTX-sensitive G proteins regulate the distribution of connexin43 within cells.
2001-10
Effects of monensin and forage:concentrate ratio on feed intake, endocrine, and ovarian function in beef heifers.
2001-09-15
Hyaluronan enters keratinocytes by a novel endocytic route for catabolism.
2001-09-14
A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages.
2001-09-01
Spatio-temporal expression of a gene encoding a putative RNA-binding protein during the early larval development of the mollusc Patella vulgata.
2001-09
Fatal rhabdomyolysis after acute sodium monensin (Rumensin) toxicity: case report.
2001-09
Yolk granules are differentially acidified during embryo development in the stick insect Carausius morosus.
2001-09
Regulation of epidermal growth factor receptor endocytosis by wortmannin through activation of Rab5 rather than inhibition of phosphatidylinositol 3-kinase.
2001-09
Expression of P-glycoprotein in the chicken.
2001-09
Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells.
2001-08-10
Bradykinin increases Na(+)-K(+) pump activity in cultured guinea-pig tracheal smooth muscle cells.
2001-08
The effects of insulin, glucose, and pyruvate on the kinetics of leptin secretion.
2001-08
Matrix vesicles and media vesicles as nonclassical pathways for the secretion of m-Calpain from MC3T3-E1 cells.
2001-07-20
Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival.
2001-07
Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts.
2001-07
Effect of monensin on the performance and nitrogen utilization of lactating dairy cows consuming fresh forage.
2001-07
Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast.
2001-07
Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro.
2001-07
Signaling pathways initiated in macrophages after engagement of type A scavenger receptors.
2001-07
LC/MS confirmation of ionophores in animal feeds.
2001-06-22
The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145.
2001-06-19
Evaluation of monensin and brefeldin A for flow cytometric determination of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in monocytes.
2001-06-15
Studies on chemical modification of monensin IX. Synthesis of 26-substituted monensins and their Na+ ion transport activity.
2001-06
Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
2001-06
Stimulated cord blood lymphocytes have a low percentage of Th1 and Th2 cytokine secreting T cells although their activation is similar to adult controls.
2001-05-01
Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells.
2001-05
Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Gal beta1-3GalNac alpha-) expression seen in colon cancer.
2001-05
Colocalization of beta 1,4galactosyltransferase with mannose 6-phosphate receptor in monensin-induced TGN-derived structures.
2001-02
HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset.
2001
Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes.
2001
Molecular and cellular mechanisms of adipose secretion: comparison of leptin and angiotensinogen.
2001
Patents

Sample Use Guides

Monensin is taken orally at a dose of 73 g/ton feed (quail), 54-90 g/ton feed (turkeys), 90-110 g/ton feed (chickens), 0.14-0.42 mg/pound body weight (cattle fed in confinement for slaughter, growing cattle, mature reproducing beef cows), 0.14-1 mg/pound body weight (calves), 20 g/ton feed (goats).
Route of Administration: Oral
In Vitro Use Guide
Eimeria tenella (Coccidia, Sporozoa) was incubated in media containing 1 ppm, 10 ppm or 100 ppm of monesin and free merozoites were destroyed after 20 min. Dose of 125 ppm monensin was found to bring about an equivalent protective effect against an infection with 40,000 Eimeria tenella oocysts.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:19:17 GMT 2025
Edited
by admin
on Mon Mar 31 18:19:17 GMT 2025
Record UNII
1GS872GAFV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-343257
Preferred Name English
MONENSIN SODIUM
GREEN BOOK   MART.   USP   USP-RS  
Common Name English
2-(2-ETHYLOCTAHYDRO-3'-METHYL-5'-(TETRAHYDRO-6-HYDROXY-6-(HYDROXYMETHYL)-3,5-DIMETHYL-2H-PYRAN-2-YL)(2,2'-BIFURAN-5-YL))-9-HYDROXY-.BETA.-METHOXY-.ALPHA.,.GAMMA.,2,8-TETRAMETHYL-1,6-DIOXASPIRO(4.5)DECAN-7-BUTANOIC ACID SODIUM SALT
Common Name English
MONENSIN SODIUM [GREEN BOOK]
Common Name English
MONENSIN SODIUM [USP IMPURITY]
Common Name English
SODIUM MONENSIN
Common Name English
MONENSIN SODIUM [USP MONOGRAPH]
Common Name English
MONENSIN SODIUM [USP-RS]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C277
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID2045573
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
FDA UNII
1GS872GAFV
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
PUBCHEM
23690927
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
RS_ITEM_NUM
1445481
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
CAS
22373-78-0
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
ChEMBL
CHEMBL256105
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
NCI_THESAURUS
C82249
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
NSC
343257
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
ECHA (EC/EINECS)
244-941-7
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
SMS_ID
300000023789
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
DRUG BANK
DBSALT001710
Created by admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY